These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24325724)

  • 21. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.
    Rey-Santano C; Mielgo VE; Gomez-Solaetxe MA; Bianco F; Salomone F; Loureiro B
    Crit Care Med; 2020 Jun; 48(6):e523-e531. PubMed ID: 32301841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS.
    Ramanathan R
    J Perinatol; 2006 May; 26 Suppl 1(Suppl 1):S51-6; discussion S63-4. PubMed ID: 16625226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Have we been down this road before?
    Lutchman D
    J Perinatol; 2010 Oct; 30(10):698-9; author reply 698. PubMed ID: 20877366
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro and in vivo comparison between poractant alfa and the new generation synthetic surfactant CHF5633.
    Ricci F; Murgia X; Razzetti R; Pelizzi N; Salomone F
    Pediatr Res; 2017 Feb; 81(2):369-375. PubMed ID: 27973472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choosing a right surfactant for respiratory distress syndrome treatment.
    Ramanathan R
    Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.
    Baroutis G; Kaleyias J; Liarou T; Papathoma E; Hatzistamatiou Z; Costalos C
    Eur J Pediatr; 2003 Jul; 162(7-8):476-480. PubMed ID: 12709796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poractant alfa versus bovine lipid extract surfactant: prospective comparative effectiveness study.
    Lemyre B; Lacaze-Masmonteil T; Shah PS; Bodani J; Doucette S; Dunn M; Louis D; Monterrosa L; Mukerji A; Schmölzer GM; Singh B; Wong J; Ye XY; Offringa M
    J Perinatol; 2022 Apr; 42(4):468-475. PubMed ID: 35177795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surfactant therapy: past, present and future.
    Speer CP; Sweet DG; Halliday HL
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S22-4. PubMed ID: 23809343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bovine or Porcine: Does the Type of Surfactant Matter?
    Boshoff Coyles L; Joolay Y; Tooke L
    J Trop Pediatr; 2020 Oct; 66(5):534-541. PubMed ID: 32112649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratracheal atomized surfactant provides similar outcomes as bolus surfactant in preterm lambs with respiratory distress syndrome.
    Milesi I; Tingay DG; Zannin E; Bianco F; Tagliabue P; Mosca F; Lavizzari A; Ventura ML; Zonneveld CE; Perkins EJ; Black D; Sourial M; Dellacá RL
    Pediatr Res; 2016 Jul; 80(1):92-100. PubMed ID: 26954481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy and safety of late surfactant preparations: a retrospective study.
    Lane MD; Kishnani S; Udemadu O; Danquah SE; Treadway RM; Langman A; Balevic S; Jackson WM; Laughon M; Hornik CP; Greenberg RG; Clark RH; Zimmerman KO
    J Perinatol; 2021 Nov; 41(11):2639-2644. PubMed ID: 34285358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surfactant history. Great discovery for the smallest children].
    Bohlin K; Blennow M; Curstedt T
    Lakartidningen; 2009 Dec; 106(52):3492-5. PubMed ID: 20151506
    [No Abstract]   [Full Text] [Related]  

  • 35. Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials.
    Sánchez Luna M; Bacher P; Unnebrink K; Martinez-Tristani M; Ramos Navarro C
    J Perinatol; 2020 Aug; 40(8):1121-1134. PubMed ID: 32051542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal-derived surfactant treatment of respiratory distress syndrome in premature neonates: a review.
    Fujii AM; Carillo M
    Drugs Today (Barc); 2009 Sep; 45(9):697-709. PubMed ID: 19956811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison efficacy of Curosurf and Survanta in preterm infants with respiratory distress syndrome.
    Mirzarahimi M; Barak M
    Pak J Pharm Sci; 2018 Mar; 31(2):469-472. PubMed ID: 29618436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calfactant: a review of its use in neonatal respiratory distress syndrome.
    Onrust SV; Dooley M; Goa KL
    Paediatr Drugs; 1999; 1(3):219-43. PubMed ID: 10937453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome.
    Wyble L; Santeiro ML
    Ann Pharmacother; 1997 Jun; 31(6):787-8. PubMed ID: 9184726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.